Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case. Atak, M. F., Farabi, B., Akbayrak, A., Kalelioğlu, M. B., & Rao, B. K. Journal of Cosmetic Dermatology, 20(8):2387–2389, August, 2021.
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case [link]Paper  doi  bibtex   
@article{atak_acute_2021,
	title = {Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with {COVID}-19 without hydroxychloroquine use: {Report} of the first case},
	volume = {20},
	copyright = {All rights reserved},
	issn = {1473-2165},
	shorttitle = {Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with {COVID}-19 without hydroxychloroquine use},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/34139069},
	doi = {10.1111/jocd.14304},
	language = {eng},
	number = {8},
	journal = {Journal of Cosmetic Dermatology},
	author = {Atak, Mehmet Fatih and Farabi, Banu and Akbayrak, Atiye and Kalelioğlu, Mehmet Berati and Rao, Babar K.},
	month = aug,
	year = {2021},
	pages = {2387--2389},
}

Downloads: 0